Galux
PrivateLast Round
Series B
Feb 9, 2026
Total Funding Raised
$46.33M
Momentum Score
50 /100
Company Overview
Galux is a biotechnology company that has developed an AI-powered drug design platform to identify and create novel therapeutics for a variety of diseases.
Sector
Healthcare & Life Sciences
Verticals
Drug Discovery, Biotechnology, Medical AI
Business Model
B2B
Customer Profile
Services & Consulting, Revenue Share
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Galux Comps
Public and private peers based on sector, stage, and business model.
Galux Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series B | Feb 9, 2026 | ||||
| Series A | Sep 30, 2022 | ||||
| Pre Seed | Apr 1, 2021 |
Galux Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| InterVest | Series B, Series A, Pre Seed |
| KDBC-L&S Digital Innovation Investment Fund | Series A |
| SL Investment | Series B |
| DAYLI Partners | Series B |
| Pathway Capital Management | Series B |
| Mirae Asset Securities | Series B |
| TKG Ventures | Series B |
Market signals
Structured signals derived from secondary market and firmographic data.
- Apr 16, 2026
Will attend and present at the AACR 2026 conference.
- Apr 16, 2026
Preclinical data on pd-1/il-18v immunocytokine to be presented at AACR 2026.
Galux Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Galux's valuation, stock price, and market status.
